NCT06603857

Skin Care Regimen for Improving Photoaging Signs on the Face

A Prospective, Placebo-controlled, Double-blinded, Randomized Clinical Trial Evaluating the Efficacy and Tolerability of Pre and Post Care Skincare Regimen Paired With 1927nm Diode Fractional Laser for Photodamage on the Face

• Status: Not Yet Recruiting
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Goldman, Butterwick, Fitzpatrick and Groff · Academic / Other
• Sex: All
• Age: 30 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Compare the effectiveness of laser treatment using CE Ferulic versus vehicle pre/post laser.

Detailed description

Evaluate the efficacy and tolerability of a Skinceuticals CE Ferulic® when used once daily over the course of 14 weeks with 2-week pre-treatment period and 12-week treatment period in pairing with two pre-elected laser treatments with 1927nm non-ablative fractional diode laser treatment for improving skin photoaging signs on the face.

Conditions

• Improve Photoaging Signs

Interventions

Type	Name	Description
DRUG	CE Ferulic	CE Ferulic serum regimen combined with laser treatment
DRUG	Sham Comparator	Vehicle serum regimen combined with laser treatment
DEVICE	1927nm (Clear and Brilliant Perméa®)	non-ablative fractional diode laser

Timeline

• Start date: 2024-09-27
• Primary completion: 2024-12-31
• Completion: 2025-02-28
• First posted: 2024-09-19
• Last updated: 2024-09-19

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study